Clinical Trial Update: Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated induction therapy with docetaxel in combination with cisplatin and 5-fluorouracil for nasopharyngeal carcinoma in children and adolesc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Nasopharyngeal Neoplasms, Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2010-03-25